Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Smith New Court was a prominent British investment bank and stockbroking firm that played a pivotal role in the London financial markets during the late 20th century. Originally founded as Smith Brothers, a firm of stock jobbers, it evolved into a leading market maker and was particularly noted for its joint venture with N M Rothschild & Sons. The firm was a major player during the 'Big Bang' deregulation of the UK financial markets in 1986. In 1995, Smith New Court was acquired by Merrill Lynch for approximately $840 million, marking a significant consolidation in the global investment banking industry.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Smith New Court.